Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of VE303 to Treat Hepatic Encephalopathy

NCT04899115 is registered in ClinicalTrials.gov with Patricia Bloom as lead sponsor.

NCT NCT04899115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04899115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of VE303 to Treat Hepatic Encephalopathy
Lead sponsor
Patricia Bloom
Phase
Phase 2
Overall status
Completed
Start date
August 6, 2021
Completion date
August 30, 2023
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hepatic encephalopathy